BioCentury
ARTICLE | Clinical News

Aplidin plitidepsin regulatory update

September 26, 2016 7:00 AM UTC

PharmaMar submitted an MAA to EMA for Aplidin plitidepsin in combination with dexamethasone to treat relapsed or refractory multiple myeloma (MM). The submission is based on data from the Phase III AD...